hearScreen™ selected as Accelerate2030 finalist

July 10, 2017

Search for articles by category

Co-initiated by Impact Hub Geneva and the UNDP, the programme is designed to help innovative ventures, which have a high potential to offer solutions towards social, economic and environmental needs, to compete in the international market. It connects winners to a global network of expert partners to assist them to develop and grow in a number of ways, mentoring them to become investment-ready and giving them access to the support of over 15,000 social innovators.

It is tailored specifically for each winner to give them assistance where they most need it. Entrants, who come from 17 countries across four continents, must have a product which is already tried and tested but ready to impact new markets.

We believe our hearScreen™ product is the perfect candidate for the Accelerate2030 programme! It was the first product we launched as part of our mission to provide affordable access to healthcare in areas where there is a severe shortage of health personnel and lack of screening programmes. It offers a hearing screening solution via a mobile phone application which is as accurate as traditional methods, but faster, cheaper and easier to use.

hearScreen™ has already won a number of awards, including first place in the 2015 Philips Innovation Fellows Competition, the 2015 Innovation Edge award (SA Innovation Summit), and the 2015 SA Innovation Award - Community Innovation Category. It was also one of the top 21 finalists in the Innovation Prize for Africa 2014 Award.

Hearing loss is the silent epidemic, an invisible, and therefore often underestimated, disabling condition. It has pervasive and far reaching effects on development in children including speech, language, cognition and socio-emotional well-being and is one of the major barriers to educational success.

In adults, its effects include social isolation, increased depression and cognitive decline with a threefold increased risk of developing dementia. It also results in higher unemployment rates, lower earning capacity, poor overall health, fatigue, and increased health care costs and mortality rates.

With hearScreen™ we are able to facilitate decentralised community­ based services by minimally trained persons to detect adults and children with hearing loss in underserved areas and help them to receive care. Currently, we're involved with several community projects including the following;

  • Tirelo Bosha project where we enabled 80 community healthcare workers and 24 school health nurses to screen the hearing of 70 000 adults and children throughout Tshwane over the next 18 months
  • Tshwane Vodacom and Department of Health pilot project which ran from April to June screening Grade 1 learners at 5 Primary Schools Gugulethu where we screened more than 800 elderly people in June in township communities across Cape Town
  • Kyalitsha which aims to achieve 10 000 screenings within the next 24 months

We have several other hearing and vision products and to date have conducted over 70 000 tests across 25 countries worldwide. Of those screened, 6 976 have been identified with hearing loss.

We envisage being able to connect 1 million people with healthy hearing and vision services globally by 2020 using our solutions, and this aim will be more achievable if we are selected as an Accelerate2030 winner and become eligible for their programme. The programme will give us the opportunity to broaden our reach and achieve our vision of healthy hearing for everyone, everywhere, with the help of Accelerate2030’s global network of experts. ![accelerate2030]({% asset_path accelerate2030-WEBSITE-BANNER.jpg %})

The next step in the process is for us to submit a video to the panel of judges to answer a series of questions. The final judging process will be conducted remotely from Geneva where the judges will select the 10 winners for the programme. The winners will be invited to Geneva to participate in a Bootcamp in Switzerland towards the end of the year.

We’ll keep you posted!


For more information on hearX Group, please visit: hearxgroup.com

Disclaimer: The opinions expressed in the publications are those of the authors. They do not reflect the opinions or beliefs of hearX Group or its subsidiaries. The information contained herein is solely for informational purposes. It is not intended to be a substitute for professional medical advice and should not be relied upon as healthcare or medical advice. You are advised to seek guidance from your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking medical advice or care because of the content published herein. If you choose to rely on any information provided by hearX Group or its subsidiaries, you do so entirely at your own risk.

Newsletter

hearX is committed to protecting your privacy and ensuring that personal information is collected and used lawfully and transparently. We use the information provided to contact you about relevant products, services and content. You may unsubscribe at any time. Privacy Policy

Press and mediaPublished researchCareersShipping and returnsPAIA manual
BlogImpact reportsContact usTerms and conditionsPricing
hearX Group info@hearxgroup.com US: +1 (415) 825-3064 RSA: +27 (0) 12 030-0268
Lexie Hearing sales@lexiehearing.com +1 (800) 499-1336
hearX is SOC2® compliant.

This globally recognized attestation validates our commitment to critical security standards to protect and secure client data

FDA Registered | ISO 13485 Certified | SAHPRA Registered | HIPAA Compliant | POPIA Compliant

To report unethical behavior, misconduct or harassment click here.

For any feedback or complaints, please contact: support@hearxgroup.com.

© 2016-2024 hearX IP (Pty) Ltd. Copyright in this work including its layout and the design contained herein is reserved and the making of copies is prohibited.